Literature DB >> 15187863

Repetitively stretched tendon fibroblasts produce inflammatory mediators.

James H-C Wang1, Zhaozhu Li, Guoguang Yang, Mustafa Khan.   

Abstract

We studied the expression of cytosolic phospholipase-A2 and activity of secretory phospholipase-A2 by human patellar tendon fibroblasts subjected to cyclic mechanical stretching. The effect of different stretching frequencies on the production of prostaglandin-E2 and expression of cyclooxygenase enzyme were also examined. An in vitro system that can control alignment, shape, and mechanical loading conditions of tendon fibroblasts was used for this study. Cyclic stretching of fibroblasts increased the expression level of cytosolic phospholipase-A2 by 88% and activity level of secretory phospholipase-A2 by 190%, compared with those of nonstretched fibroblasts. Cyclic stretching of tendon fibroblasts at 0.1 Hz and 1.0 Hz also increased prostaglandin-E2 production by 40% and 69%, respectively. Furthermore, cyclooxygenase-1 and cyclooxygenase-2 expression levels were increased in a stretching frequency-dependent manner, but cyclooxygenase-2 expression was increased more than that of cyclooxygenase-1. Because cytosolic phospholipase-A2 and secretory phospholipase-A2 are involved in the production of prostaglandin-E2 and other inflammatory mediators, this study suggests that regulation of phospholipase-A2 expression level may be an alternative approach to control in vivo tendon inflammation. The results of this study also may explain in part why activities that involve repetitive motion and high frequency loading of tendons are more likely to result in tendon inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187863     DOI: 10.1097/01.blo.0000126337.65685.e4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Structure-function relationships in tendons: a review.

Authors:  M Benjamin; E Kaiser; S Milz
Journal:  J Anat       Date:  2008-03       Impact factor: 2.610

Review 2.  Healing of subcutaneous tendons: Influence of the mechanical environment at the suture line on the healing process.

Authors:  Elsayed Ibraheem Elsayed Massoud
Journal:  World J Orthop       Date:  2013-10-18

3.  [Tenocytes and the extracellular matrix : a reciprocal relationship].

Authors:  S Milz; B Ockert; R Putz
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

4.  EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment.

Authors:  Bhavani P Thampatty; Hongxia Li; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-09-15       Impact factor: 3.688

5.  Effect of Metformin on Development of Tendinopathy Due to Mechanical Overloading in an Animal Model.

Authors:  Jianying Zhang; Feng Li; Daibang Nie; Kentaro Onishi; MaCalus V Hogan; James H-C Wang
Journal:  Foot Ankle Int       Date:  2020-11-12       Impact factor: 2.827

Review 6.  Animal models for the study of tendinopathy.

Authors:  S J Warden
Journal:  Br J Sports Med       Date:  2006-11-24       Impact factor: 13.800

7.  Remission in psoriatic arthritis.

Authors:  Kurt de Vlam; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

8.  Coordinate regulation of IL-1beta and MMP-13 in rat tendons following subrupture fatigue damage.

Authors:  Hui B Sun; Yonghui Li; David T Fung; Robert J Majeska; Mitchell B Schaffler; Evan L Flatow
Journal:  Clin Orthop Relat Res       Date:  2008-05-10       Impact factor: 4.176

9.  Deciphering the pathogenesis of tendinopathy: a three-stages process.

Authors:  Sai-Chuen Fu; Christer Rolf; Yau-Chuk Cheuk; Pauline Py Lui; Kai-Ming Chan
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-12-13

10.  Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease.

Authors:  Stephanie Georgina Dakin; Jayesh Dudhia; Natalie Jayne Werling; Dirk Werling; Dilkush Robert Ephrem Abayasekara; Roger Kenneth Whealands Smith
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.